The Vigabatrin REMS Program is called for by the FDA to make sure educated risk-benefit decisions before starting therapy, and to ensure proper use vigabatrin while individuals are dealt with. It is not possible for your doctor to recognize when vision loss will occur.
The most common side effect of SABRIL in children 3 to 16 years is weight gain. With serious vision loss, you might only be able to see things directly before you (sometimes called one-track mind"). You are at risk for vision loss with any kind of quantity of SABRIL.
If you are expectant or intend to get expectant, inform your medical care service provider. If vision screening can not be done, your doctor might proceed suggesting SABRIL, but will not be able to look for any kind of vision loss. Your healthcare service provider might stop prescribing SABRIL for you (or your youngster)if vision examinations are not done on a regular basis.